METHOD FOR STABILIZING SUSPENSIONS OF RED BLOOD CELLS ENCAPSULATING ACTIVE INGREDIENT AND SUSPENSIONS OBTAINED Russian patent published in 2018 - IPC A61K9/50 A61K35/18 

Abstract RU 2668688 C2

FIELD: medicine.

SUBSTANCE: method for obtaining a stabilized suspension of red blood cells encapsulating an active ingredient from resealed red blood cells incorporating the active ingredient includes the incubation of resealed red blood cells in an incubation solution at osmolality of at least 280 m Osmole/kg for 30 minutes or longer, the incubation solution does not contain agents that induce denaturation of the red blood cell membrane, and the liquid medium is then removed from the incubated suspension and the obtained red blood cells are suspended in a solution allowing the injection of this suspension to a patient, wherein said incubation solution does not contain bridging or cross-linking agents.

EFFECT: invention relates to a method for stabilizing red blood cell suspensions comprising an active ingredient.

20 cl, 1 dwg, 6 tbl, 4 ex

Similar patents RU2668688C2

Title Year Author Number
PHARMACEUTICAL COMPOSITION COMPRISING ERYTHROCYTES CONTAINING ENZYME DEPENDENT ON PYRIDOXALPHOSPHATE AND COFACTOR THEREOF 2015
  • Godfrin, Yann
  • Bourgeaux, Vanessa
  • Gay, Fabien
  • Cortese, Thomas
RU2744659C2
PHARMACEUTICAL COMPOSITION CONTAINING ERYTHROCYTES IN WHICH AN ENZYME DEPENDENT ON PYRIDOXALPHOSPHATE IS ENCLOSED, AND COFACTOR THEREOF 2015
  • Godfren Yann
  • Borzho Vanessa
  • Ge Faben
  • Kortez Toma
RU2697086C2
METHOD OF TREATING CANCER IN A MAMMAL, INCLUDING A HUMAN, USING METHIONINE AND ASPARAGINE DEPLETION 2017
  • Agera Karin
  • Berle Villi
  • Ge Faben
  • Godfren Yan
RU2733389C2
ARGININE DEIMINASE ENCAPSULATED IN ERYTHROCYTES, AND THEIR USE IN TREATMENT OF CANCER AND ARGINASE-1 DEFICIENCY 2018
  • Dufour, Emmanuelle
  • Blanc, Manuel
  • Meyzaud, Aurelien
RU2773220C2
PROCESS FOR PREPARATION OF ERYTHROCYTES LOADED WITH ONE OR MORE SUBSTANCES OF PHARMACEUTICAL INTEREST AND SO OBTAINED ERYTHROCYTES 2014
  • Mambrini Dzhovanni
  • Benatti Luka
  • Kapogrossi Dzhovanni
  • Mandolini Marko
RU2670070C2
METHOD FOR INCLUDING BIOLOGICALLY ACTIVE COMPONENTS IN ERYTHROCYTES BY METHOD OF FLOW HYPOOSMOTIC DIALYSIS 2021
  • Ataullakhanov Fazoil Inoyatovich
  • Zejnalov Azer Mamedovich
  • Sinauridze Elena Ivanovna
  • Koleva Larisa
RU2791817C1
DEVICE FOR THE INCLUSION OF BIOLOGICALLY ACTIVE COMPONENTS IN RED BLOOD CELLS BY THE CONTINUOUS FLOW DIALYSIS METHOD 2021
  • Ataullakhanov Fazoil Inoyatovich
  • Borsakova Daria Valerevna
  • Bovt Elizaveta Andreevna
  • Danielian Akop Dzhivanovich
  • Zeinalov Azer Mamedovich
  • Koleva Larisa
  • Kushnir Nikita Sergeevich
  • Protasov Evgenii Sergeevich
  • Sinauridze Elena Ivanovna
  • Suvorova Anna Sergeevna
RU2772209C1
HAEMOGLOBIN COMPOSITION 2010
  • Abuchovski Abrakham
  • Sloshberg Stiven
  • O'Kher Kit
RU2589254C2
MEDICAMENT FOR TREATMENT OF ACUTE MYELOID LEUKEMIA (AML) 2013
  • Godfrin Yann
RU2667639C2
COMPOSITION FOR INDUCTION OF SPECIFIC IMMUNOLOGICAL TOLERANCE 2010
  • Godfrin, Yann
  • Banz, Alice
RU2782223C2

RU 2 668 688 C2

Authors

Godfren Yann

Borzho Vanessa

Belli Zherom

Dates

2018-10-02Published

2014-05-07Filed